Retatrutide 20mg Injection (Lyophilized)

Retatrutide 20mg Injection is a research-grade, lyophilized peptide formulation supplied in sterile vial format for pharmaceutical research and development applications. Retatrutide is a synthetic peptide compound evaluated in advanced metabolic and multi-receptor research programs. This product is manufactured and supplied strictly for international export to licensed research institutions, biotechnology companies, and pharmaceutical R&D organizations. It is not intended for clinical treatment, retail distribution, or consumer use.

Active Ingredient

• Retatrutide – 20 mg per vial
  Retatrutide is a laboratory-synthesized peptide studied in controlled research environments for its interaction with multiple metabolic receptor pathways.

Therapeutic Use
This product is supplied for pharmaceutical research and R&D use only. Retatrutide 20 mg Injection is intended exclusively for non-clinical laboratory research, analytical studies, formulation development, and investigational programs conducted by authorized institutions. AmeriDrugs does not provide medical advice, therapeutic claims, or guidance for human use.

Dosage Form

• Sterile lyophilized powder for injection

• Supplied in sealed pharmaceutical-grade glass vials

• Reconstitution, handling, and experimental use are restricted to qualified research professionals operating under approved laboratory and institutional protocols

Quality & Manufacturing Standards
Retatrutide 20 mg Injection is manufactured in a controlled environment following stringent quality management systems aligned with international export and research material standards. Each batch undergoes validated analytical testing to confirm identity, purity, and consistency.

• Purity: ≥99% by HPLC

• Research-grade injectable material

• Controlled manufacturing and documented quality assurance processes

Packaging Information

• Sterile amber glass vial

• Aluminum flip-off seal with rubber stopper

• Secure secondary packaging suitable for international shipping and export logistics

• Packaging designed to maintain product integrity during storage and long-term research use

Target Buyers
This product is intended exclusively for supply to:

• Pharmaceutical research and development companies

• Biotechnology and life science research firms

• Academic and institutional research laboratories

• Contract research organizations (CROs)

• Licensed importers of research-grade injectable materials

It is not intended for retail sale, prescription dispensing, clinical treatment, or direct human consumption.

Regulatory & Compliance Note
Retatrutide 20 mg Injection is supplied strictly as a Research Use Only (RUO) product.
For pharmaceutical research and R&D use only.
Not for retail sale, clinical use, or direct human consumption.

Importation, storage, handling, and use must comply with the regulatory, customs, and research material requirements of the destination country. AmeriDrugs operates solely as an export-focused pharmaceutical and research material supplier and does not promote this product for therapeutic, diagnostic, or patient-facing applications.